# ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

> **NCT00656305** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 147 (actual)

## Conditions studied

- Bone Metastases
- Multiple Myeloma

## Interventions

- **DEVICE:** ExAblate MRfFUS
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT00656305
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656305, "ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00656305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*